Complete response (CR) was an uncommon event in elderly myeloma patients until novel agents were combined with standard oral melphalan-prednisone. This analysis assesses the impact of treatment response on progression-free survival (PFS) and overall survival (OS). We retrospectively analyzed 1175 ne...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!